娱乐大麻使用对中神经心理功能的影响
Lucy Roberts-West1, Sallie Baxendale1,2
1University College Hospital, London, United Kingdom.
Epilepsy & behavior reports
|November 13, 2023
概括
在患者中,娱乐性大麻使用会放大认知缺陷,特别是在学习和注意力方面. 这强调了在评估患者的认知功能时需要考虑大麻使用的必要性.
科学领域:
- 神经科学是一个神经科学.
- 临床神经学 临床神经学
背景情况:
- 大麻使用与一般人群的认知障碍有关.
- 患有的人 (PWE) 面临由于伴随疾病而导致认知困难的风险更高.
- 有限的研究存在于大麻对PWE认知的影响.
研究的目的:
- 研究经常使用大麻对患者认知功能的影响.
- 为了比较大麻使用者和非使用者之间的认知表现,PWE.
主要方法:
- 横截面研究比较了42个使用大麻的PWE与254个不使用PWE.
- 认知评估包括对智力储备,记忆,语言和处理速度的测试.
- 对焦虑和抑郁症进行控制的回归模型.
主要成果:
- 大麻使用报告了5.9%的PWE,在男性中更常见.
- 大麻使用与较低的智力储备 (阅读智商) 和减少新信息编码 (列表学习) 相关联.
- 在大麻使用者中观察到,在回忆任务期间,他们更容易分心.
结论:
- 娱乐性大麻使用加剧了PWE的学习缺陷和分心能力.
- 在临床评估的认知障碍时,大麻使用应该被考虑.
- 调查结果强调了在PWE管理中评估物质使用的重要性.
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
206
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
206
An Overview of Psychoactive Drugs
236
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
236
Arteries of the Lower Limbs
193
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
193
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
130
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
130
Antiepileptic Drugs: GABAergic Pathway Potentiators
423
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
423
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
318
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318


